ZA888250B - Human tissue-type plasminogen activator variant - Google Patents

Human tissue-type plasminogen activator variant

Info

Publication number
ZA888250B
ZA888250B ZA888250A ZA888250A ZA888250B ZA 888250 B ZA888250 B ZA 888250B ZA 888250 A ZA888250 A ZA 888250A ZA 888250 A ZA888250 A ZA 888250A ZA 888250 B ZA888250 B ZA 888250B
Authority
ZA
South Africa
Prior art keywords
plasminogen activator
human tissue
type plasminogen
activator variant
variant
Prior art date
Application number
ZA888250A
Other languages
English (en)
Inventor
Adair J Hotchkiss
J Hotchkiss Adair
John V O'connor
V O'connor John
Michael W Spellman
W Spellman Michael
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA888250B publication Critical patent/ZA888250B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA888250A 1987-11-06 1988-11-03 Human tissue-type plasminogen activator variant ZA888250B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11809887A 1987-11-06 1987-11-06

Publications (1)

Publication Number Publication Date
ZA888250B true ZA888250B (en) 1990-07-25

Family

ID=22376492

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA888250A ZA888250B (en) 1987-11-06 1988-11-03 Human tissue-type plasminogen activator variant

Country Status (18)

Country Link
EP (2) EP0387290B1 (ko)
JP (1) JPH03500843A (ko)
KR (1) KR920009521B1 (ko)
AT (1) ATE151812T1 (ko)
AU (2) AU2804989A (ko)
CA (1) CA1341609C (ko)
DD (1) DD286613A5 (ko)
DE (1) DE3855874T2 (ko)
DK (1) DK175482B1 (ko)
FI (1) FI102970B1 (ko)
HU (1) HU215230B (ko)
IL (1) IL88247A0 (ko)
NO (1) NO307612B1 (ko)
NZ (1) NZ226829A (ko)
PH (1) PH30064A (ko)
PT (1) PT88938B (ko)
WO (1) WO1989004368A1 (ko)
ZA (1) ZA888250B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246850A (en) * 1990-07-31 1993-09-21 Genentech, Inc. DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells
CA2086835C (en) * 1990-07-31 2002-04-02 Bruce A. Keyt Tissue plasminogen activator variants with decreased clearance
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
DK0643772T3 (da) 1992-06-03 1998-02-02 Genentech Inc Glycosyleringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber
DK0827751T3 (da) * 1996-09-06 2003-03-31 Chemo Sero Therapeut Res Inst Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid
US7084118B2 (en) 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001786A1 (en) * 1982-10-28 1984-05-10 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
EP0293394B2 (en) * 1986-01-31 2003-10-29 Genetics Institute, LLC Novel thrombolytic proteins
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it
ZA887556B (en) * 1987-10-09 1989-07-26 Monsanto Co Modified tissue plasminogen activator

Also Published As

Publication number Publication date
FI902239A0 (fi) 1990-05-04
HU890157D0 (en) 1990-12-28
DK112290A (da) 1990-07-06
PT88938B (pt) 1993-05-31
NO901995D0 (no) 1990-05-04
AU2804989A (en) 1989-06-01
DK112290D0 (da) 1990-05-04
AU2131792A (en) 1992-11-19
EP0387290B1 (en) 1997-04-16
FI102970B (fi) 1999-03-31
DK175482B1 (da) 2004-11-08
NO901995L (no) 1990-07-05
CA1341609C (en) 2011-02-01
KR920009521B1 (ko) 1992-10-17
NO307612B1 (no) 2000-05-02
EP0754753A1 (en) 1997-01-22
HU215230B (hu) 2000-03-28
DE3855874D1 (de) 1997-05-22
NZ226829A (en) 1991-06-25
KR890701733A (ko) 1989-12-21
FI102970B1 (fi) 1999-03-31
DD286613A5 (de) 1991-01-31
JPH03500843A (ja) 1991-02-28
ATE151812T1 (de) 1997-05-15
EP0387290A1 (en) 1990-09-19
AU658909B2 (en) 1995-05-04
IL88247A0 (en) 1989-06-30
PH30064A (en) 1996-11-08
PT88938A (pt) 1989-11-30
WO1989004368A1 (en) 1989-05-18
HUT54209A (en) 1991-01-28
DE3855874T2 (de) 1997-09-11

Similar Documents

Publication Publication Date Title
GB2189249B (en) Modified human tissue-type plasminogen activator and its preparation
IL80659A0 (en) Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them
PH30064A (en) Novel human tissue-type plasminogen activator variant
GB8819607D0 (en) Novel combination
AU602681B2 (en) Modified plasminogen activators
NZ223291A (en) Modified tissue-type plasminogen activator
DE59008693D1 (de) Gewebs-Plasminogen-Aktivator-Derivat.
IE860355L (en) Modified tissue-type plasminogen activator
IL109759A0 (en) Human tissue-type plasminogen activator having modified functional carbohydrate residues, which retains its biological activity and is characterized by an increased in vivo half-life
AU608232C (en) Modified tissue plasminogen activator
IE870208L (en) Modified tissue plasminogen activator
AU7554687A (en) Modified tissue plasminogen activator
IE871856L (en) "modified tissue plasminogen activator"
IE883342L (en) Human tissue-type plasminogen activator variant